Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06967168

HeEL Pain Pathways Feasibility Study

At the moment, no-one is sure what the best way to treat heel pain is. The purpose of this research is to try out some study methods to prepare for a future clinical trial, that will assess how helpful combining different treatments are for people with heel pain (plantar fasciitis). At this stage, the aim is only to test the study processes and ask for feedback - that is why this is called a feasibility study. No experimental techniques or devices will be tested. All of the treatments in the study are routinely carried out in NHS clinics, but participants will be allocated to different combinations of treatments.

Each participant will be asked to complete questionnaires and a diary for around six months in total. Some people will also be invited to take part in an interview or focus group discussion.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Podiatry Department, Cardiff Royal Infirmary

Cardiff, Wales, CF24 0SZ, United Kingdom

Location status: Recruiting

Location contact

Nia J Jones, PhD

CONTACT

[email protected]

Ruth L Poole, MPhil

CONTACT

[email protected]

02921844771

About this study

This single-centre study will test the feasibility of using a SMART design to provide tailored treatment pathways for people with heel pain. The study will investigate areas of uncertainty relating to the feasibility of a future full-scale SMART study. Key objectives are to assess whether the research design is feasible (including whether enough people can be recruited), and to determine whether the proposed adaptive intervention pathways are acceptable to patients and NHS staff.

50 people with heel pain will be recruited from referrals received by the Podiatry department. Participants will be randomly assigned to two groups initially - half will have a virtual consultation with a podiatrist; the other half will receive a self-help video. After following the advice at home for at least 4 weeks, anyone (in either group) who has not responded to treatment will be offered an assessment in an outpatient clinic. They will then be randomised equally again to receive either an orthotic device (shoe insole) or a course of 'Shockwave therapy' (using a non-invasive device to deliver ultrasound to the injured area).

As well as collecting Patient Reported Outcome Measures (PROMs) for a total duration of 6 months for each participant, process evaluation methods (interviews and focus groups) will be used to talk to patients. They will be asked about their experiences of adaptive intervention pathways and of participating in the feasibility study. The researchers will also interview staff involved in trial design and delivery (clinical members of the study delivery team) about similar topics from a different perspective. Progression criteria will be used to help decide whether to continue with the plan to run a full-scale trial to test effectiveness of the treatment pathways.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults aged 18 years or over
  • Have symptomatic heel pain (in one or both feet)
  • Able to speak, read and understand written and spoken English or Welsh
  • Able to provide remote informed consent
  • Access to internet and email, or DVD player, with technical support from family, friends or carers if necessary.

Exclusion criteria

  • Taken part in a prescribed exercise intervention or used prescribed insoles (past 3 months)
  • History of major trauma or fracture of the lower leg or below ankle surgery
  • Heel pain secondary to a systemic condition/syndrome/malignancy
  • Requires ankle-foot orthoses or lower limb device (splint)
  • Diabetes or peripheral neuropathy
  • History of inflammatory joint disease or autoimmune condition
  • Chronic pain syndrome
  • Pregnancy
  • Pacemaker or other electrical implant
  • Blood clotting disorder (haemophilia), blood clot (thrombosis), or current use of anticoagulant medication
  • Cortisone injection therapy within the last two weeks
  • Unable to complete exercises in self-help resources.

Treatment and study plan

Virtual consultation

Behavioral

Virtual (telephone) consultation with a podiatrist, who will provide self-management advice to the participant including advice on footwear, massage, and stretching. Supplemented by written advice leaflets.

Self-help video

Behavioral

Self-help video providing self-management advice to the participant including advice on footwear, massage, and stretching. Available online or as a DVD.

Orthotics

Device

Provision of orthotics following an in-person musculoskeletal assessment by a podiatrist to check foot function, footwear, and position of feet, ankles, knees, and hip.

Podiatrists prescribe, produce, and fit orthotic devices to be worn inside footwear. The devices used in this feasibility study will be selected according to individual patient needs. All will have regulatory certification (CE mark) and will be used in accordance with the manufacturer's Instructions For Use.

Other names: Shoe inserts

Shockwave therapy

Device

A 3-week course of Shockwave therapy following an in-person musculoskeletal assessment by a podiatrist to check foot function, footwear, and position of feet, ankles, knees, and hip.

Extracorporeal shockwave therapy (ESWT) is delivered by a podiatrist in an outpatient clinic. Most patients lie down during the procedure. The machine passes pulses of energy through the skin towards the injured area of the heel. This encourages the body to respond and aims to stimulate the healing process. Participants will need to attend the clinic approximately once a week for three weeks to complete the course of treatment.

Other names: ESWT

Primary outcomes

  1. Feasibility of recruitment (Progression Criterion 1)

    Time frame: Through study completion, an average of 1 year.

    Average number of participants per month. Stop if <2; Change if 2-6; Go if >6.

  2. Fidelity of clinical delivery of the correct treatment at the correct stage (Progression Criterion 2)

    Time frame: Through study completion, an average of 1 year.

    Proportion of participants who receive the treatments they are allocated to after each randomisation. Stop if <50%; Change if 50-80%; Go if >80%.

  3. Appropriateness of tailoring criteria and its threshold (Progression Criterion 3)

    Time frame: Through study completion, an average of 1 year.

    Minimum number of participants in any of the SMART outcome subgroups (A-F) at the end of the study. Stop if <1; Change if 1-4; Go if >4.

  4. Rate of retention/loss to follow-up, including withdrawals (Progression Criterion 4)

    Time frame: Through study completion, an average of 1 year.

    Proportion of participants who fail to complete the study. Stop if >50%; Change if 20-50%; Go if <20%.

  5. Acceptability of adaptive intervention pathways amongst patients

    Time frame: Through study completion, an average of 1 year.

    Qualitative interviews and/or focus groups will be carried out with participants to determine the acceptability of adaptive interventions and the study design, including barriers and facilitators to following self-management advice.

  6. Acceptability of adaptive intervention pathways amongst staff

    Time frame: Through study completion, an average of 1 year.

    Qualitative interviews will be carried out with study staff to determine acceptability of adaptive interventions, including barriers and facilitators to delivering the SMART study.

Secondary outcomes

  1. Estimated effect size and variance

    Time frame: Baseline and Week 26

    Composite outcome data from validated PROM - Revised Foot Function Index (short)

Other outcomes

  1. Acceptability of data collection tools (quantitative)

    Time frame: Through study completion, an average of 1 year.

    Completeness of PROM questionnaires and participant diaries/records.

  2. Acceptability of data collection tools (qualitative)

    Time frame: Through study completion, an average of 1 year.

    Qualitative information from staff and participant interviews/focus groups.

  3. Feasibility of collecting health service resource use data (staff time)

    Time frame: Through study completion, an average of 1 year.

    Any deviations from the usual amount of staff time required will be reported in narrative form by the delivery team.

  4. Feasibility of collecting health service resource use data (equipment)

    Time frame: Through study completion, an average of 1 year.

    Any deviations from standard care with respect to the equipment required will be reported in narrative form by the delivery team.

  5. Feasibility of collecting health service resource use data (number of appointments)

    Time frame: Through study completion, an average of 1 year.

    Participants will be invited to indicate their frequency of use of healthcare services in patient diaries. Each week they will be asked how many appointments they have had.

  6. Feasibility of collecting health service resource use data (type of appointment)

    Time frame: Through study completion, an average of 1 year.

    Participants be asked which type(s) of healthcare professional they have had appointments with (GP, nurse, physiotherapist, other) in weekly patient diaries.

Study contacts

Contact information is provided by the study sponsor or research team.

Nia J Jones, PhD

CONTACT

[email protected]

+442921844771

Ruth L Poole, MPhil

CONTACT

[email protected]

+442921844771

Sponsors and collaborators

Lead sponsor

Cardiff and Vale University Health Board

Other Gov

Registry information

Official study title

Feasibility of Developing Personalised Treatment Pathways for Relief of Plantar Heel Pain Using a Sequential Multiple Assignment Randomised Trial (SMART) Study Design

Acronym: HELPP

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
May 13, 2025
Registry last updated
May 13, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.